Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Molecular Psychiatry
|
July 22, 2015
De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease
A Rovelet-Lecrux, C Charbonnier, D Wallon, et al.
Molecular Psychiatry
|
April 5, 2012
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease
C Pottier, D Hannequin, S Coutant, et al.
Breast Cancer Research and Treatment
|
August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests
P Pujol, D Stoppa Lyonnet, T Frebourg, et al.
Human Molecular Genetics
|
July 1, 1996
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
R Sherrington, S Froelich, S Sorbi, et al.
American Journal of Human Genetics
|
February 1, 1997
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex
H Bickeböller, D Campion, A Brice, et al.
Bulletin Du Cancer
|
July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]
T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Journal of Medical Genetics
|
April 16, 2005
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer
T Frebourg, C Oliveira, P Hochain, et al.
Molecular Psychiatry
|
August 26, 2015
SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease
G Nicolas, C Charbonnier, D Wallon, et al.
Science (New York, N.Y.)
|
October 18, 2003
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina, C Von Kalle, M Schmidt, et al.
Molecular Psychiatry
|
December 14, 2016
17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression
K Le Guennec, O Quenez, G Nicolas, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Molecular Psychiatry
|
July 22, 2015
De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease
A Rovelet-Lecrux, C Charbonnier, D Wallon, et al.
Molecular Psychiatry
|
April 5, 2012
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease
C Pottier, D Hannequin, S Coutant, et al.
Breast Cancer Research and Treatment
|
August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests
P Pujol, D Stoppa Lyonnet, T Frebourg, et al.
Human Molecular Genetics
|
July 1, 1996
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant
R Sherrington, S Froelich, S Sorbi, et al.
American Journal of Human Genetics
|
February 1, 1997
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex
H Bickeböller, D Campion, A Brice, et al.
Bulletin Du Cancer
|
July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]
T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Journal of Medical Genetics
|
April 16, 2005
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer
T Frebourg, C Oliveira, P Hochain, et al.
Molecular Psychiatry
|
August 26, 2015
SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease
G Nicolas, C Charbonnier, D Wallon, et al.
Science (New York, N.Y.)
|
October 18, 2003
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina, C Von Kalle, M Schmidt, et al.
Molecular Psychiatry
|
December 14, 2016
17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression
K Le Guennec, O Quenez, G Nicolas, et al.
Page
of 11